Contact Us

In addition to assembling a diversified team with expertise in each area of branding, investor relations, public relations and social media, we have developed a network of brands and partners to best serve both public and private companies. By engaging any one of our services, you will benefit from decades of experience accumulated by helping more than 250 companies achieve greater success.

Contact Us

    Your Name *

    Your Email *

    Subject

    Message:

    Get Your Copy of The StocksToBuyNow Newsletter

    You’re just a click and email verification away from joining hundreds of other subscribers receiving weekly trading ideas!

    From Our Blog

    Soligenix Inc. (NASDAQ: SNGX) Strengthens Rare Disease Pipeline Program Through UK Regulatory Innovation Designation

    March 20, 2026

    Regulatory recognition from international health authorities can significantly shape the trajectory of emerging therapies worldwide, particularly in rare disease development where clinical pathways are often complex and resource intensive. Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on developing and commercializing treatments for rare diseases and unmet medical needs, recently received such recognition as its […]

    Rotate your device 90° to view site.